Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07314320) titled 'A Study to Detect Radioactivity of [14C]-OPC-167832 in Urine and Feces in Healthy Men' on Dec. 18, 2025.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition:
Healthy Volunteers
Intervention:
Drug: [14C]-OPC-167832
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: November 20, 2023
Target Sample Size: 8
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.g...